Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey

Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey

<i>Aim:</i> This study was conducted to evaluate the impact of complementary and alternative medicine (CAM) in patients with irritable bowel syndrome (IBS) as assessed by the Rome IV criteria. <i>Methods:</i> Consecutive patients referring for IBS were re-evaluated according...

Descripció completa

Dades bibliogràfiques
Autors principals:	Tiziana Larussa, Marianna Rossi, Evelina Suraci, Raffaella Marasco, Maria Imeneo, Ludovico Abenavoli, Francesco Luzza
Format:	Article
Idioma:	English
Publicat:	MDPI AG 2019-02-01
Col·lecció:	Medicina
Matèries:	irritable bowel syndrome complementary and alternative medicine patient-centered care Rome IV criteria nutritional supplements health behaviors public health
Accés en línia:	https://www.mdpi.com/1010-660X/55/2/46

Ítems similars

Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization
per: Tiziana Larussa, et al.
Publicat: (2019-08-01)

Angry Gut: Irritable Bowel Syndrome
per: Izrum Shafi Rajput, et al.
Publicat: (2022-04-01)

Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study
per: Igor V. Maev, et al.
Publicat: (2023-02-01)

Irritable bowel syndrome in view of the rome IV criteria (2016)
per: D. T. Dicheva, et al.
Publicat: (2018-04-01)

Optimizing the treatment of patients with irritable bowel syndrome: focus on increased compliance
per: D. N. Andreev, et al.
Publicat: (2019-05-01)

Frequency and severity of irritable bowel syndrome in cigarette smokers, Turkey 2019
per: Melike Mercan Başpınar, et al.
Publicat: (2022-03-01)

Irritable bowel syndrome – diagnostic and therapeutic recommendations considering the place of antispasmodics
per: Anna Cybulska
Publicat: (2019-11-01)

Prevalence and risk factors of irritable bowel syndrome in adolescents
per: Muzal Kadim, et al.
Publicat: (2021-10-01)

Association between Insomnia and Irritable Bowel Syndrome among Adolescents in South Korea: A Quantitative Cross-Sectional Study
per: Yun-Yi Yang
Publicat: (2021-12-01)

The association between obesity and irritable bowel syndrome among a sample of patients attending the primary health care centers in Erbil city
per: Zana Mustafa Mahmood, et al.
Publicat: (2022-06-01)

The association between obesity and irritable bowel syndrome among a sample of patients attending the primary health care centers in Erbil city
per: Zana Mustafa Mahmood, et al.
Publicat: (2022-06-01)

Prevalence and risk factors of irritable bowel syndrome in Irkutsk
per: V. V. Tsukanov, et al.
Publicat: (2021-10-01)

Inflammatory factor in the clinical picture and therapy of irritable bowel syndrome
per: V. M. Makhov, et al.
Publicat: (2018-10-01)

Mineral water as non-medicamentous way in treatment of irritable bowel syndrome (IBS)
per: V. V. Skvortsov, et al.
Publicat: (2018-04-01)

Editorial: Irritable bowel syndrome: what is known and what is missing in daily practice
per: Khaled Jadallah, et al.
Publicat: (2023-07-01)

Role of psychiatric disorders and irritable bowel syndrome in asthma patients
per: Ayse Yilmaz, et al.
Publicat: (2011-01-01)

A Comprehensive Look at Irritable Bowel Syndrome and its Associated Factors Considering the Rome IV Criteria: A Penalized Smoothly Clipped Absolute Deviation Regression Approach in the Pars Cohort Study
per: Peyman Arasteh, et al.
Publicat: (2018-07-01)

Influence of the requirement for abdominal pain in the diagnosis of irritable bowel syndrome with constipation (IBS-C) under the Rome IV criteria using data from a large Japanese population-based internet survey
per: Masanori Kosako, et al.
Publicat: (2018-12-01)

Review of Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome
per: Yunzhou SHI, Hui ZHENG, Min CHEN, Zhigang LI, Shuguang YU
Publicat: (2022-05-01)

Irritable Bowel Syndrome: News from an Old Disorder
per: Ana Isabel Ferreira, et al.
Publicat: (2019-11-01)

High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria
per: Mohamed G. Shiha, et al.
Publicat: (2020-08-01)

Dietary habits as associated factors with irritable bowel syndrome among medical students: evidence from a cross-sectional study
per: Mueataz A. Mahyoub, et al.
Publicat: (2024-08-01)

Are patients with polycystic ovary syndrome more prone to irritable bowel syndrome?
per: Małgorzata Kałużna, et al.
Publicat: (2022-04-01)

Irritable bowel syndrome - from etiopathogenesis to therapy
per: Biljana Radovanovic-Dinic, et al.
Publicat: (2018-03-01)

Bone Mineralization in Celiac Disease
per: Tiziana Larussa, et al.
Publicat: (2012-01-01)

Irritable Bowel Syndrome (IBS) Among Jordanian Adults: Uncovering the Underdiagnosed and The Triggering Factors
per: Derar Abdel-Qader
Publicat: (2024-02-01)

The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors
per: Ardhi Rahman Ahani, et al.
Publicat: (2022-03-01)

How much bloating in the irritable bowel syndrome?
per: Pop Lucian Liviu, et al.
Publicat: (2018-12-01)

Planning a Clinical Development Programme for Medicinal Products for Irritable Bowel Syndrome: An Analysis of the European Medicines Agency’s Recommendations
per: E. A. Gerasimets, et al.
Publicat: (2024-09-01)

The prevalence of irritable bowel syndrome among Saudi population in Riyadh by use of Rome IV criteria and self-reported dietary restriction
per: Hussein S Amin, et al.
Publicat: (2021-01-01)

Irritable bowel syndrome: The present view of the problem
per: I V Maev, et al.
Publicat: (2013-08-01)

Upper gastrointestinal endoscopic findings in functional constipation and irritable bowel syndrome diagnosed using the Rome IV criteria: a cross-sectional survey during a medical check-up in Japan
per: Koji Otani, et al.
Publicat: (2023-05-01)

Gastroesophageal reflux disease and irritable bowel syndrome - prevalence and overlap.
per: Patrycja Kmiotek, et al.
Publicat: (2019-09-01)

Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori
per: Tiziana Larussa, et al.
Publicat: (2018-01-01)

Irritable bowel syndrome and biliary tract pathology. Clinical analysis
per: T. E. Polunina
Publicat: (2020-10-01)

Irritable bowel syndrome and its associated factors in adolescents
per: Lara Fillekes, et al.
Publicat: (2014-12-01)

Optimization of treatment of irritable bowel syndrome in children
per: O.B. Hanzii, et al.
Publicat: (2019-04-01)

Irritable Bowel Syndrome: assessment of prevalence and risk factors in Saudi University students using Rome IV Criteria
per: Ramzi Mohammed Hakami, et al.
Publicat: (2019-12-01)

Probiotic therapy in patients with irritable bowel syndrome: does it have a real role?
per: Iman Mohamed Fawzy, et al.
Publicat: (2021-07-01)

Prevalence of irritable bowel syndrome and its associated risk factors among university students of Bangladesh
per: Anita Das, et al.
Publicat: (2022-06-01)